{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:52:14Z","timestamp":1794862334778,"version":"4.9.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K15031"],"award-info":[{"award-number":["JP21K15031"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ama121013"],"award-info":[{"award-number":["JP23ama121013"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24ama221121"],"award-info":[{"award-number":["JP24ama221121"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MC_UP_A025_1012"],"award-info":[{"award-number":["MC_UP_A025_1012"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MC_UP_A025_1012"],"award-info":[{"award-number":["MC_UP_A025_1012"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>LAT1 (SLC7A5) transports large neutral amino acids and plays pivotal roles in cancer proliferation, immune response and drug delivery. Despite recent advances in structural understanding of LAT1, how it discriminates substrates and inhibitors including the clinically relevant drugs remains elusive. Here we report six structures of LAT1 across three conformations with bound ligands, elucidating its substrate transport and inhibitory mechanisms. JPH203 (also known as nanvuranlat or KYT-0353), an anticancer drug in clinical trials, traps LAT1 in an outward-facing state with a U-shaped conformer, with its amino-phenylbenzoxazol moiety pushing against transmembrane helix 3 (TM3) and bending TM10. Physiological substrates like \u029f-Phe lack such effects, whereas melphalan poses steric hindrance, explaining its inhibitory activity. The \u201cclassical\u201d system L inhibitor BCH induces an occluded state critical for transport, confirming its substrate-like behavior. These findings provide a structural basis for substrate recognition and inhibition of LAT1, guiding future drug design.<\/jats:p>","DOI":"10.1038\/s41467-025-56903-w","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T12:03:30Z","timestamp":1739534610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Structural basis of anticancer drug recognition and amino acid transport by LAT1"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1507-805X","authenticated-orcid":false,"given":"Yongchan","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6894-7239","authenticated-orcid":false,"given":"Ryuichi","family":"Ohgaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6908-9953","authenticated-orcid":false,"given":"Satoshi","family":"Ogasawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rangana","family":"Warshamanage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5442-7582","authenticated-orcid":false,"given":"Keitaro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garib","family":"Murshudov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1813-7008","authenticated-orcid":false,"given":"Osamu","family":"Nureki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5748-4670","authenticated-orcid":false,"given":"Takeshi","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8126-286X","authenticated-orcid":false,"given":"Yoshikatsu","family":"Kanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,14]]},"reference":[{"key":"56903_CR1","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1152\/physrev.1990.70.1.43","volume":"70","author":"H Christensen","year":"1990","unstructured":"Christensen, H. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol. Rev. 70, 43\u201377 (1990).","journal-title":"Physiol. Rev."},{"key":"56903_CR2","doi-asserted-by":"publisher","first-page":"23629","DOI":"10.1074\/jbc.273.37.23629","volume":"273","author":"Y Kanai","year":"1998","unstructured":"Kanai, Y. et al. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J. Biol. Chem. 273, 23629\u201323632 (1998).","journal-title":"J. Biol. Chem."},{"key":"56903_CR3","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0026-895X(24)12322-X","volume":"61","author":"H Uchino","year":"2002","unstructured":"Uchino, H. et al. Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. Mol. Pharm. 61, 729\u2013737 (2002).","journal-title":"Mol. Pharm."},{"key":"56903_CR4","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1210\/endo.142.10.8418","volume":"142","author":"EC Friesema","year":"2001","unstructured":"Friesema, E. C. et al. Thyroid hormone transport by the heterodimeric human system L amino acid transporter. Endocrinology 142, 4339\u20134348 (2001).","journal-title":"Endocrinology"},{"key":"56903_CR5","doi-asserted-by":"crossref","unstructured":"Kanai Y. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharmacol. Therapeut. 230, 107964 (2021).","DOI":"10.1016\/j.pharmthera.2021.107964"},{"key":"56903_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00424-002-0973-z","volume":"445","author":"F Verrey","year":"2003","unstructured":"Verrey, F. System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pfl\u00fcgers Arch. 445, 529\u2013533 (2003).","journal-title":"Pfl\u00fcgers Arch."},{"key":"56903_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","volume":"34","author":"D Fotiadis","year":"2013","unstructured":"Fotiadis, D., Kanai, Y. & Palac\u00edn, M. The SLC3 and SLC7 families of amino acid transporters. Mol. Asp. Med. 34, 139\u2013158 (2013).","journal-title":"Mol. Asp. Med."},{"key":"56903_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.mam.2012.12.006","volume":"34","author":"S Bodoy","year":"2013","unstructured":"Bodoy, S., Fotiadis, D., Stoeger, C., Kanai, Y. & Palac\u00edn, M. The small SLC43 family: Facilitator system l amino acid transporters and the orphan EEG1. Mol. Asp. Med. 34, 638\u2013645 (2013).","journal-title":"Mol. Asp. Med."},{"key":"56903_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0140-6736(89)90567-9","volume":"334","author":"Y Mishima","year":"1989","unstructured":"Mishima, Y. et al. Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet 334, 388\u2013389 (1989).","journal-title":"Lancet"},{"key":"56903_CR10","doi-asserted-by":"publisher","first-page":"43S","DOI":"10.2967\/jnumed.107.045930","volume":"49","author":"C Plathow","year":"2008","unstructured":"Plathow, C. & Weber, W. A. Tumor cell metabolism imaging. J. Nucl. Med. 49, 43S\u201363S (2008).","journal-title":"J. Nucl. Med"},{"key":"56903_CR11","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/j.cell.2016.11.013","volume":"167","author":"DC T\u0103rlungeanu","year":"2016","unstructured":"T\u0103rlungeanu, D. C. et al. Impaired amino acid transport at the blood brain barrier is a cause of autism spectrum disorder. Cell 167, 1481\u20131494.e18 (2016).","journal-title":"Cell"},{"key":"56903_CR12","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/j.bcp.2013.03.022","volume":"85","author":"D Dickens","year":"2013","unstructured":"Dickens, D. et al. Transport of gabapentin by LAT1 (SLC7A5). Biochem Pharm. 85, 1672\u20131683 (2013).","journal-title":"Biochem Pharm."},{"key":"56903_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0006-8993(00)02758-X","volume":"879","author":"T Kageyama","year":"2000","unstructured":"Kageyama, T. et al. The 4F2hc\/LAT1 complex transports l-DOPA across the blood\u2013brain barrier. Brain Res. 879, 115\u2013121 (2000).","journal-title":"Brain Res."},{"key":"56903_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1349-7006.2009.01386.x","volume":"101","author":"K Oda","year":"2010","unstructured":"Oda, K. et al. L\u2010Type amino acid transporter 1 inhibitors inhibit tumor cell growth. Cancer Sci. 101, 173\u2013179 (2010).","journal-title":"Cancer Sci."},{"key":"56903_CR15","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/leu.2014.338","volume":"29","author":"C Rosilio","year":"2015","unstructured":"Rosilio, C. et al. L-type amino-acid transporter 1 (LAT1): A therapeutic target supporting growth and survival of T-cell lymphoblastic lymphoma\/T-cell acute lymphoblastic leukemia. Leukemia 29, 1253\u20131266 (2015).","journal-title":"Leukemia"},{"key":"56903_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13046-018-0907-z","volume":"37","author":"P H\u00e4fliger","year":"2018","unstructured":"H\u00e4fliger, P. et al. The LAT1 inhibitor JPH203 reduces growth of thyroid carcinoma in a fully immunocompetent mouse model. J. Exp. Clin. Canc Res. 37, 234 (2018).","journal-title":"J. Exp. Clin. Canc Res."},{"key":"56903_CR17","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s10637-020-00924-3","volume":"38","author":"N Okano","year":"2020","unstructured":"Okano, N. et al. First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors. Invest N. Drug 38, 1495\u20131506 (2020).","journal-title":"Invest N. Drug"},{"key":"56903_CR18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1200\/JCO.2023.41.4_suppl.494","volume":"41","author":"J Furuse","year":"2023","unstructured":"Furuse, J. et al. Nanvuranlat, an L-type amino acid transporter (LAT1) inhibitor for patients with pretreated advanced refractory biliary tract cancer (BTC): Primary endpoint results of a randomized, double-blind, placebo-controlled phase 2 study. J. Clin. Oncol. 41, 494\u2013494 (2023).","journal-title":"J. Clin. Oncol."},{"key":"56903_CR19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41586-019-1011-z","volume":"568","author":"R Yan","year":"2019","unstructured":"Yan, R., Zhao, X., Lei, J. & Zhou, Q. Structure of the human LAT1\u20134F2hc heteromeric amino acid transporter complex. Nature 568, 127\u2013130 (2019).","journal-title":"Nature"},{"key":"56903_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-021-00247-4","volume":"7","author":"R Yan","year":"2021","unstructured":"Yan, R. et al. Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter. Cell Discov. 7, 16 (2021).","journal-title":"Cell Discov."},{"key":"56903_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep43580","volume":"7","author":"D Dickens","year":"2017","unstructured":"Dickens, D. et al. Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol. Sci. Rep. 7, 43580 (2017).","journal-title":"Sci. Rep."},{"key":"56903_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73757-y","volume":"10","author":"J Cosco","year":"2020","unstructured":"Cosco, J. et al. ATP modulates SLC7A5 (LAT1) synergistically with cholesterol. Sci. Rep. 10, 16738 (2020).","journal-title":"Sci. Rep."},{"key":"56903_CR23","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41594-019-0237-7","volume":"26","author":"Y Lee","year":"2019","unstructured":"Lee, Y. et al. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc. Nat. Struct. Mol. Biol. 26, 510\u2013517 (2019).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"56903_CR24","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41421-020-00207-4","volume":"6","author":"R Yan","year":"2020","unstructured":"Yan, R., Zhou, J., Li, Y., Lei, J. & Zhou, Q. Structural insight into the substrate recognition and transport mechanism of the human LAT2\u20134F2hc complex. Cell Discov. 6, 82 (2020).","journal-title":"Cell Discov."},{"key":"56903_CR25","doi-asserted-by":"publisher","first-page":"e2113573118","DOI":"10.1073\/pnas.2113573118","volume":"118","author":"CF Rodriguez","year":"2021","unstructured":"Rodriguez, C. F. et al. Structural basis for substrate specificity of heteromeric transporters of neutral amino acids. Proc. Natl. Acad. Sci. 118, e2113573118 (2021).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"56903_CR26","doi-asserted-by":"publisher","first-page":"12681","DOI":"10.1111\/jcmm.15840","volume":"24","author":"J Zaugg","year":"2020","unstructured":"Zaugg, J. et al. Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno\u2010foetal amino acid transport. J. Cell. Mol. Med. 24, 12681\u201312693 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"56903_CR27","doi-asserted-by":"publisher","first-page":"5480","DOI":"10.1073\/pnas.1218165110","volume":"110","author":"EG Geier","year":"2013","unstructured":"Geier, E. G. et al. Structure-based ligand discovery for the Large-neutral Amino Acid Transporter 1, LAT-1. Proc. Natl. Acad. Sci. USA 110, 5480\u20135485 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"56903_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ics.2005.02.012","volume":"1277","author":"QR Smith","year":"2005","unstructured":"Smith, Q. R. Carrier-mediated transport to enhance drug delivery to brain. Int. Congr. Ser. 1277, 63\u201374 (2005).","journal-title":"Int. Congr. Ser."},{"key":"56903_CR29","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1248\/bpb.31.2126","volume":"31","author":"K Hosoya","year":"2008","unstructured":"Hosoya, K. et al. Evaluation of amino acid-mustard transport as L-type amino acid transporter 1 (LAT1)-mediated alkylating agents. Biol. Pharm. Bull. 31, 2126\u20132130 (2008).","journal-title":"Biol. Pharm. Bull."},{"key":"56903_CR30","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1021\/jm00386a017","volume":"30","author":"DR Haines","year":"1987","unstructured":"Haines, D. R., Fuller, R. W., Ahmad, S., Vistica, D. T. & Marquez, V. E. Selective cytotoxicity of a system L specific amino acid nitrogen mustard. J. Med Chem. 30, 542\u2013547 (1987).","journal-title":"J. Med Chem."},{"key":"56903_CR31","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1016\/j.bmcl.2010.04.086","volume":"20","author":"J Matharu","year":"2010","unstructured":"Matharu, J., Oki, J., Worthen, D. R., Smith, Q. R. & Crooks, P. A. Regiospecific and conformationally restrained analogs of melphalan and dl-2-NAM-7 and their affinities for the large neutral amino acid transporter (system LAT1) of the blood\u2013brain barrier. Bioorg. Med. Chem. Lett. 20, 3688\u20133691 (2010).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"56903_CR32","first-page":"1","volume":"85","author":"D Drew","year":"2015","unstructured":"Drew, D. & Boudker, O. Shared molecular mechanisms of membrane transporters. Annu. Rev. Biochem. 85, 1\u201330 (2015).","journal-title":"Annu. Rev. Biochem."},{"key":"56903_CR33","doi-asserted-by":"publisher","first-page":"8563","DOI":"10.1021\/bi050543r","volume":"44","author":"M Klingenberg","year":"2005","unstructured":"Klingenberg, M. Ligand\u2212protein interaction in biomembrane carriers. The induced transition fit of transport catalysis \u2020. Biochemistry 44, 8563\u20138570 (2005).","journal-title":"Biochemistry"},{"key":"56903_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53065-w","volume":"9","author":"C Barthelemy","year":"2019","unstructured":"Barthelemy, C. & Andr\u00e9, B. Ubiquitylation and endocytosis of the human LAT1\/SLC7A5 amino acid transporter. Sci. Rep. 9, 16760 (2019).","journal-title":"Sci. Rep."},{"key":"56903_CR35","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ejps.2012.11.014","volume":"48","author":"H Ylikangas","year":"2013","unstructured":"Ylikangas, H. et al. Structure\u2013activity relationship study of compounds binding to large amino acid transporter 1 (LAT1) based on pharmacophore modeling and in situ rat brain perfusion. Eur. J. Pharm. Sci. 48, 523\u2013531 (2013).","journal-title":"Eur. J. Pharm. Sci."},{"key":"56903_CR36","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1248\/bpb.31.1096","volume":"31","author":"CS Kim","year":"2008","unstructured":"Kim, C. S. et al. BCH, an inhibitor of system L amino acid transporters, induces apoptosis in cancer cells. Biol. Pharm. Bull. 31, 1096\u20131100 (2008).","journal-title":"Biol. Pharm. Bull."},{"key":"56903_CR37","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1111\/cas.15006","volume":"112","author":"Y Saito","year":"2021","unstructured":"Saito, Y. & Soga, T. Amino acid transporters as emerging therapeutic targets in cancer. Cancer Sci. 112, 2958\u20132965 (2021).","journal-title":"Cancer Sci."},{"key":"56903_CR38","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1016\/j.bmcl.2016.04.023","volume":"26","author":"E Augustyn","year":"2016","unstructured":"Augustyn, E. et al. LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs. Bioorg. Med. Chem. Lett. 26, 2616\u20132621 (2016).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"56903_CR39","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1007\/s11064-016-1996-8","volume":"41","author":"M Gynther","year":"2016","unstructured":"Gynther, M. et al. Amino acid promoieties alter valproic acid pharmacokinetics and enable extended brain exposure. Neurochem. Res. 41, 2797\u20132809 (2016).","journal-title":"Neurochem. Res."},{"key":"56903_CR40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ijpharm.2018.04.025","volume":"544","author":"J K\u00e4rkk\u00e4inen","year":"2018","unstructured":"K\u00e4rkk\u00e4inen, J. et al. Structural properties for selective and efficient l-type amino acid transporter 1 (LAT1) mediated cellular uptake. Int. J. Pharm. 544, 91\u201399 (2018).","journal-title":"Int. J. Pharm."},{"key":"56903_CR41","doi-asserted-by":"publisher","first-page":"107964","DOI":"10.1016\/j.pharmthera.2021.107964","volume":"230","author":"Y Kanai","year":"2022","unstructured":"Kanai, Y. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharmacol. Ther. 230, 107964 (2022).","journal-title":"Pharmacol. Ther."},{"key":"56903_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jphs.2017.01.006","volume":"133","author":"P Kongpracha","year":"2017","unstructured":"Kongpracha, P. et al. Structure-activity relationship of a novel series of inhibitors for cancer type transporter L-type amino acid transporter 1 (LAT1). J. Pharm. Sci. 133, 96\u2013102 (2017).","journal-title":"J. Pharm. Sci."},{"key":"56903_CR43","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1093\/emboj\/21.4.580","volume":"21","author":"C Meier","year":"2002","unstructured":"Meier, C., Ristic, Z., Klauser, S. & Verrey, F. Activation of system L heterodimeric amino acid exchangers by intracellular substrates. EMBO J. 21, 580\u2013589 (2002).","journal-title":"EMBO J."},{"key":"56903_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25563-x","volume":"12","author":"G Gauthier-Coles","year":"2021","unstructured":"Gauthier-Coles, G. et al. Quantitative modelling of amino acid transport and homeostasis in mammalian cells. Nat. Commun. 12, 5282 (2021).","journal-title":"Nat. Commun."},{"key":"56903_CR45","doi-asserted-by":"crossref","unstructured":"Hutchinson, K. & Schlessinger, A. Comprehensive characterization of LAT1 cholesterol-binding sites. J. Chem. Theory Comput. 20, 3349\u20133358 (2024).","DOI":"10.1021\/acs.jctc.3c01391"},{"key":"56903_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47948-4","volume":"15","author":"D Wu","year":"2024","unstructured":"Wu, D. et al. The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation. Nat. Commun. 15, 3711 (2024).","journal-title":"Nat. Commun."},{"key":"56903_CR47","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.str.2016.03.004","volume":"24","author":"CL Morales-Perez","year":"2016","unstructured":"Morales-Perez, C. L., Noviello, C. M. & Hibbs, R. E. Manipulation of subunit stoichiometry in heteromeric membrane proteins. Structure 24, 797\u2013805 (2016).","journal-title":"Structure"},{"key":"56903_CR48","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nprot.2017.094","volume":"13","author":"F Hagn","year":"2018","unstructured":"Hagn, F., Nasr, M. L. & Wagner, G. Assembly of phospholipid nanodiscs of controlled size for structural studies of membrane proteins by NMR. Nat. Protoc. 13, 79\u201398 (2018).","journal-title":"Nat. Protoc."},{"key":"56903_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature10750","volume":"482","author":"T Hino","year":"2012","unstructured":"Hino, T. et al. G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody. Nature 482, 237\u2013240 (2012).","journal-title":"Nature"},{"key":"56903_CR50","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: Algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290\u2013296 (2017).","journal-title":"Nat. Methods"},{"key":"56903_CR51","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jsb.2012.09.006","volume":"180","author":"SHW Scheres","year":"2012","unstructured":"Scheres, S. H. W. RELION: Implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519\u2013530 (2012).","journal-title":"J. Struct. Biol."},{"key":"56903_CR52","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.42166","volume":"7","author":"J Zivanov","year":"2018","unstructured":"Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).","journal-title":"eLife"},{"key":"56903_CR53","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nmeth.4193","volume":"14","author":"SQ Zheng","year":"2017","unstructured":"Zheng, S. Q. et al. MotionCor2: Anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331\u2013332 (2017).","journal-title":"Nat. Methods"},{"key":"56903_CR54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jsb.2015.08.008","volume":"192","author":"A Rohou","year":"2015","unstructured":"Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216\u2013221 (2015).","journal-title":"J. Struct. Biol."},{"key":"56903_CR55","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41592-019-0575-8","volume":"16","author":"T Bepler","year":"2019","unstructured":"Bepler, T. et al. Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs. Nat. Methods 16, 1153\u20131160 (2019).","journal-title":"Nat. Methods"},{"key":"56903_CR56","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1107\/S205225251801463X","volume":"6","author":"J Zivanov","year":"2019","unstructured":"Zivanov, J., Nakane, T. & Scheres, S. H. W. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ 6, 5\u201317 (2019).","journal-title":"IUCrJ"},{"key":"56903_CR57","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.36861","volume":"7","author":"T Nakane","year":"2018","unstructured":"Nakane, T., Kimanius, D., Lindahl, E. & Scheres, S. H. Characterisation of molecular motions in cryo-EM single-particle data by multi-body refinement in RELION. eLife 7, e36861 (2018).","journal-title":"eLife"},{"key":"56903_CR58","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"56903_CR59","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/S0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of coot. Acta Crystallogr Sect. D. Biol. Crystallogr 66, 486\u2013501 (2010).","journal-title":"Acta Crystallogr Sect. D. Biol. Crystallogr"},{"key":"56903_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1107\/S2059798317000067","volume":"73","author":"F Long","year":"2017","unstructured":"Long, F. et al. AceDRG: A stereochemical description generator for ligands. Acta Crystallogr. Sect. D: Struct. Biol. 73, 112\u2013122 (2017).","journal-title":"Acta Crystallogr. Sect. D: Struct. Biol."},{"key":"56903_CR61","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1107\/S2059798318002425","volume":"74","author":"TI Croll","year":"2018","unstructured":"Croll, T. I. ISOLDE: A physically realistic environment for model building into low-resolution electron-density maps. Acta Crystallogr. Sect. D: Struct. Biol. 74, 519\u2013530 (2018).","journal-title":"Acta Crystallogr. Sect. D: Struct. Biol."},{"key":"56903_CR62","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1107\/S2059798321009475","volume":"77","author":"K Yamashita","year":"2021","unstructured":"Yamashita, K., Palmer, C. M., Burnley, T. & Murshudov, G. N. Cryo-EM single-particle structure refinement and map calculation using Servalcat. Acta Crystallogr Sect. D. 77, 1282\u20131291 (2021).","journal-title":"Acta Crystallogr Sect. D."},{"key":"56903_CR63","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/j.1471-4159.2007.04654.x","volume":"102","author":"S Br\u00f6er","year":"2007","unstructured":"Br\u00f6er, S. et al. Alanine metabolism, transport, and cycling in the brain. J. Neurochem. 102, 1758\u20131770 (2007).","journal-title":"J. Neurochem"},{"key":"56903_CR64","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1107\/S1399004714021683","volume":"71","author":"A Brown","year":"2015","unstructured":"Brown, A. et al. Tools for macromolecular model building and refinement into electron cryo\u2010microscopy reconstructions. Acta Crystallogr. Sect. D. 71, 136\u2013153 (2015).","journal-title":"Acta Crystallogr. Sect. D."},{"key":"56903_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsb.2021.107826","volume":"214","author":"R Warshamanage","year":"2022","unstructured":"Warshamanage, R., Yamashita, K. & Murshudov, G. N. EMDA: A python package for electron microscopy data analysis. J. Struct. Biol. 214, 107826 (2022).","journal-title":"J. Struct. Biol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56903-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56903-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56903-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T12:03:35Z","timestamp":1739534615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-56903-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["56903"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-56903-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.03.567112","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,14]]},"assertion":[{"value":"5 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.L. receives research funding from J-Pharma. O.N. is a co-founder and scientific advisor of Curreio. All the other authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1635"}}